title: [The problem of residual cavity and local recurrences in surgical treatment of hepatic echinococcosis].
abstract: Results of examination and treatment of 326 patients, suffering hepatic echinococcosis, in whom 449 surgical interventions were performed, were analyzed. In 123 patients the disease recurrence was diagnosed. In 80 (17.8%) patients laparoscopic access was applied, in 261 (58.1%)--laparotomic, in 108 (24.1%)--the puncture treatment of parasitic cysts under ultrasonographic investigation control. There was established, that the residual cavity walls after echinococcectomy, if the condition of their chemical and thermal processing do not constitute a danger for the disease recurrence occurrence, but the residual cavity suppuration or formation of durably persisting residual cavities in liver is possible. So the optimal operative intervention must be echinococcectomy with partial resection of fibrose capsule with the thinned hepatic parenchyma.
authors.forename: S G
authors.initials: SG
authors.lastname: Chetverikov
authors.forename: Z M
authors.initials: ZM
authors.lastname: Akhmad
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D004322:Drainage / Q000379:methods*; D004444:Echinococcosis, Hepatic / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000469:parasitology / Q000601:surgery*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D010535:Laparoscopy / Q000379:methods*; D008099:Liver / Q000000981:diagnostic imaging / Q000187:drug effects / Q000469:parasitology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use; D011677:Punctures / Q000379:methods*; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000627:therapeutic use; D055502:Secondary Prevention; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D000871:Anthelmintics; D000891:Anti-Infective Agents, Local; D012597:Sclerosing Solutions; D011206:Povidone-Iodine; D015766:Albendazole